Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition-Reference-Cited by-同舟云学术

Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition

Published:2017-06 Issue: Volume:396 Page:117-129
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Halldorsson Skarphedinn,Rohatgi Neha,Magnusdottir Manuela,Choudhary Kumari Sonal,Gudjonsson Thorarinn,Knutsen Erik,Barkovskaya Anna,Hilmarsdottir Bylgja,Perander Maria,Mælandsmo Gunhild M.,Gudmundsson Steinn,Rolfsson Óttar

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference64 articles.

1. EMT: when epithelial cells decide to become mesenchymal-like cells;Kalluri;J. Clin. Invest.,2009

2. The basics of epithelial-mesenchymal transition;Kalluri;J. Clin. Invest.,2009

3. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease;Acloque;J. Clin. Invest.,2009

4. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits;Polyak;Nat. Rev. Cancer,2009

5. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma;Petersen;Am. J. Pathol.,2003

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of genome-scale metabolic models to the study of human diseases: A systematic review;Computer Methods and Programs in Biomedicine;2024-11

2. Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor model;Experimental and Molecular Pathology;2024-06

3. Ameliorating Old Drugs with New Tricks in the Nano Realms;ACS Applied Nano Materials;2024-02-03

4. Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development;European Journal of Pharmacology;2024-02

5. Identification of a core EMT signature that separates basal-like breast cancers into partial- and post-EMT subtypes;Frontiers in Oncology;2023-12-04